Another month is almost in the books so lets recap the recent spinoff activity and also take a look at what spinoffs the next month will bring: Spinoffs Completed Prior Month Some big spinoffs in April. April 1st – after several years of merger integration work, DowDupont (DWDP) began breaking itself up last month with the spin off… Read More »
Everyone was focused on DowDupont’s (DWDP) mega Dow (DOW) spinoff yesterday, but it wasn’t the only show in town. Ironwood Pharmaceuticals (IRWD) also completed the spinoff of Cyclerion Therapeutics (CYCN) that same day. As we previously discussed, Ironwood shareholders should have received one share of Cyclerion stock for every ten shares of IRWD stock owned. That ratio may… Read More »
Born as Microbia over twenty years ago, Ironwood Pharmaceuticals(IRWD) trades just 21% above its 2010 IPO price. It has managed to get to market with LINZESS, a treatment for IBS. Partnered with Allergan(AGN), LINZESS did $761.2 million in 2018 US sales. Now, Ironwood will be spinning off much of its R&D business as Cyclerion. Current Ironwood CEO and… Read More »